Crystal structure of (20S)-21-[4-(2-hy­droxy­propan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methyl­pent­yl)-5-pregnen-3β-ol with an unknown solvate

In the title cholesterol analogue, [systematic name: (3S,8S,9S,10R,13S,14S,17R)-17-{(S)-1-[4-(2-hy­droxy­propan-2-yl)-1H-1,2,3-triazol-1-yl]-6-methyl­heptan-2-yl}-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetra­deca­hydro-1H-cyclo­penta­[a]phenanthren-3-ol] C(32)H(53)N(3)O(2), a new chain,...

Descripción completa

Detalles Bibliográficos
Autores principales: Santalla, Hugo, Argibay, Saray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2018
Materias:
Research Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946969/
https://www.ncbi.nlm.nih.gov/pubmed/29765747
http://dx.doi.org/10.1107/S2056989018003286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946969/
https://www.ncbi.nlm.nih.gov/pubmed/29765747
http://dx.doi.org/10.1107/S2056989018003286

Ejemplares similares